UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 4, 2024 4:00 P.M.
Form:
S-1
CIK:
0001460702
Company Name:
Qualigen Therapeutics, Inc.
File Number:
333-272623